| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018160 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages |
Abstract
Blood and tissue MDSC levels correlate with several clinicopathologic factors and may predict for pCR. Future studies are needed to highlight the role of MDSC in predicting long-term outcomes and to determine the clinical implications of these findings.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Moshe C. M.D., M.A., Claudia Marcela Ph.D., Patricia M.S., Paul Ph.D., Samuel M.D., James H. Ph.D., Jin S. M.S., Paul G. M.S., Marcelo M.A., Sarah B.S., Priscilla M.L.S., Kim B.S., Andrew M.D., Steven M.D., Hamid M.D., Marc S. M.D., Christopher J. D.O.,